Cargando…

Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy

Glucose-regulated protein 94 (GRP94) is an endoplasmic reticulum (ER)-resident member of the heat shock protein 90 (HSP90) family. In physiological conditions, it plays a vital role in regulating biological functions, including chaperoning cellular proteins in the ER lumen, maintaining calcium homeo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Ji Woong, Cho, Yea Bin, Lee, Sukmook
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8002708/ https://www.ncbi.nlm.nih.gov/pubmed/33802964 http://dx.doi.org/10.3390/cells10030670

Ejemplares similares

Correction: Kim et al. Cell Surface GRP94 as a Novel Emerging Therapeutic Target for Monoclonal Antibody Cancer Therapy. Cells 2021, 10, 670
por: Kim, Ji Woong, et al.
Publicado: (2021)

Antibody-Based Targeting of Cell Surface GRP94 Specifically Inhibits Cetuximab-Resistant Colorectal Cancer Growth
por: Jeoung, Mee Hyun, et al.
Publicado: (2019)

TSPAN8 as a Novel Emerging Therapeutic Target in Cancer for Monoclonal Antibody Therapy
por: Heo, Kyun, et al.
Publicado: (2020)

Clinicopathologic and Prognostic Association of GRP94 Expression in Colorectal Cancer with Synchronous and Metachronous Metastases
por: Yun, Sumi, et al.
Publicado: (2021)

Molecular Chaperone GRP94/GP96 in Cancers: Oncogenesis and Therapeutic Target
por: Duan, Xiaofeng, et al.
Publicado: (2021)

Grp94-specific monoclonal antibody to counteract BRAF inhibitor resistance in BRAF(V600E) melanoma
por: Sabbatino, F, et al.
Publicado: (2015)

Differential requirement of GRP94 and GRP78 in mammary gland development
por: Zhu, Genyuan, et al.
Publicado: (2014)

Development and Characterization of Phage-Display-Derived Novel Human Monoclonal Antibodies against the Receptor Binding Domain of SARS-CoV-2
por: Kim, Ji Woong, et al.
Publicado: (2022)

Visualization of conformational transition of GRP94 in solution
por: Sun, Shangwu, et al.
Publicado: (2023)

GRP94 (gp96) and GRP94 N-Terminal Geldanamycin Binding Domain Elicit Tissue Nonrestricted Tumor Suppression
por: Baker-LePain, Julie C., et al.
Publicado: (2002)

Targeted Deletion of ER Chaperone GRP94 in the Liver Results in Injury, Repopulation of GRP94-Positive Hepatocytes, and Spontaneous Hepatocellular Carcinoma Development in Aged Mice
por: Chen, Wan-Ting, et al.
Publicado: (2014)

A Review of Anti-Angiogenic Targets for Monoclonal Antibody Cancer Therapy
por: Kong, Deok-Hoon, et al.
Publicado: (2017)

Glucose-Regulated Protein 94 (GRP94): A Novel Regulator of Insulin-Like Growth Factor Production
por: Argon, Yair, et al.
Publicado: (2020)

Structural Insights into Complexes of Glucose-Regulated Protein94 (Grp94) with Human Immunoglobulin G. Relevance for Grp94-IgG Complexes that Form In Vivo in Pathological Conditions
por: Pagetta, Andrea, et al.
Publicado: (2014)

Recent Advances in Monoclonal Antibody Therapy for Colorectal Cancers
por: Hwang, Kyusang, et al.
Publicado: (2021)

Anti-GRP-R monoclonal antibody antitumor therapy against neuroblastoma
por: Qiao, Jingbo, et al.
Publicado: (2022)

Co-downregulation of GRP78 and GRP94 Induces Apoptosis and Inhibits Migration in Prostate Cancer Cells
por: Lu, Tong, et al.
Publicado: (2019)

GRP & love 94 present cool jazz and smooth vocals
Publicado: (1993)

Exploring the Functional Complementation between Grp94 and Hsp90
por: Maharaj, Kevin A., et al.
Publicado: (2016)

GRP94 Is Involved in the Lipid Phenotype of Brain Metastatic Cells
por: Santana-Codina, Naiara, et al.
Publicado: (2019)

Upregulation of Phosphorylated HSP27, PRDX2, GRP75, GRP78 and GRP94 in Acquired Middle Ear Cholesteatoma Growth
por: Ho, Kuen Yao, et al.
Publicado: (2013)

OS-9 facilitates turnover of nonnative GRP94 marked by hyperglycosylation
por: Dersh, Devin, et al.
Publicado: (2014)

Bispecific Antibody-Based Immune-Cell Engagers and Their Emerging Therapeutic Targets in Cancer Immunotherapy
por: Shin, Ha Gyeong, et al.
Publicado: (2022)

The endoplasmic reticulum chaperone BiP is a closure-accelerating cochaperone of Grp94
por: Huang, Bin, et al.
Publicado: (2022)

Targeted Mutation of the Mouse Grp94 Gene Disrupts Development and Perturbs Endoplasmic Reticulum Stress Signaling
por: Mao, Changhui, et al.
Publicado: (2010)

The clinical and prognostic evaluation of GRP94 immunoexpression in Caucasian patients with colorectal adenocarcinoma
por: Brzozowa-Zasada, Marlena, et al.
Publicado: (2019)

Comprehensive analysis reveals GRP94 is associated with worse prognosis of breast cancer
por: Wang, Ting, et al.
Publicado: (2021)

Grp94 Inhibitor HCP1 Inhibits Human Dermal Fibroblast Senescence
por: Cui, Xiaoling, et al.
Publicado: (2022)

Therapeutic Monoclonal Antibodies and Emergence of Their Biosimilars
por: Jeddi-Tehrani, Mahmood
Publicado: (2018)

Expression and clinical significance of Glucose Regulated Proteins GRP78 (BiP) and GRP94 (GP96) in human adenocarcinomas of the esophagus
por: Langer, Rupert, et al.
Publicado: (2008)

Overexpression of molecular chaperons GRP78 and GRP94 in CD44(hi)/CD24(lo) breast cancer stem cells
por: Nami, Babak, et al.
Publicado: (2016)

Development and Characterization of Phage Display-Derived Monoclonal Antibodies to the S2 Domain of Spike Proteins of Wild-Type SARS-CoV-2 and Multiple Variants
por: Kim, Ji Woong, et al.
Publicado: (2023)

Grp94 acts as a mediator of curcumin-induced antioxidant defence in myogenic cells
por: Pizzo, Paola, et al.
Publicado: (2010)

Unleashing the full potential of Hsp90 inhibitors as cancer therapeutics through simultaneous inactivation of Hsp90, Grp94, and TRAP1
por: Park, Hye-Kyung, et al.
Publicado: (2020)

Decreased functional expression of Grp78 and Grp94 inhibits proliferation and attenuates apoptosis in a human gastric cancer cell line in vitro
por: ZHANG, XINCHEN, et al.
Publicado: (2015)

Therapeutic Targets of Monoclonal Antibodies Used in the Treatment of Cancer: Current and Emerging
por: Effer, Brian, et al.
Publicado: (2023)

Cell surface GRP78 as a biomarker and target for suppressing glioma cells
por: Kang, Bo Ram, et al.
Publicado: (2016)

FN14 and GRP94 expression are prognostic/predictive biomarkers of brain metastasis outcome that open up new therapeutic strategies
por: Martínez-Aranda, Antonio, et al.
Publicado: (2015)

Network-based analysis of calcium-binding protein genes identifies Grp94 as a target in human oral carcinogenesis
por: Nomura, H, et al.
Publicado: (2007)

A novel bispecific antibody dual-targeting approach for enhanced neutralization against fast-evolving SARS-CoV-2 variants
por: Kim, Ji Woong, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rf5pvgut4kbld5qt62gq2mrgth